72,234 articles
Emery–Dreifuss muscular dystrophy
Emery-Dreifuss muscular dystrophy (EDMD), also called Emery-Dreifuss syndrome, is a rare inherited muscular dystrophy with early contractures, humeroperoneal weakness, and cardiac conduction disease; genes include EMD, LMNA, FHL1, SYNE1/2, TMEM43, SUN1/2.
eMESH study
eMESH study refers to two unrelated clinical trials: EMESH 1 (NCT01676376), a feasibility study of the Kips Bay Medical eSVS Mesh external vein support for saphenous vein grafts in CABG, and eMESH Struct. 2022-23 (NCT05202938), a Sherbrooke observational PET study of cardiac energy metabolism in septic shock and heart failure.
Emestedastat (Xanamem)
Emestedastat (Xanamem, UE2343) is Actinogen Medical's oral brain-penetrant 11β-HSD1 inhibitor lowering brain cortisol, in Phase 2b/3 trials for Alzheimer's disease (XanaMIA, topline November 2026) and depression; not approved anywhere.
Emetine
Emetine is an isoquinoline alkaloid from ipecacuanha root, first isolated in 1817 by Pierre-Joseph Pelletier, used historically as an emetic and against amoebic dysentery until superseded by metronidazole.
Emetophobia
Emetophobia, or specific phobia of vomiting, is an anxiety disorder classified under specific phobias in DSM-5 and ICD-11. It mostly begins in childhood, affects far more women than men, and is treated mainly with exposure-based CBT.
EMG-COVID study
EMG-COVID (NCT05572853) is a completed Brazilian cross-sectional study of surface electromyography of respiratory muscles in 74 ICU COVID-19 patients on low-flow oxygen, stratified by SpO2/FiO2 ratio.
Emi Nishimura
Emi Nishimura (西村 栄美) is a Japanese stem cell biologist at the University of Tokyo known for identifying melanocyte stem cells and linking their loss to hair graying.
Emicizumab
Emicizumab (Hemlibra, ACE 910) is a subcutaneous bispecific IgG4 antibody bridging FIXa and FX to mimic factor VIIIa for hemophilia A prophylaxis, with or without FVIII inhibitors; HAVEN trials showed 87-97% bleeding-rate reductions.
Emil Abderhalden
Emil Abderhalden (1877–1950) was a Swiss-German physiologist and biochemist, co-founder of protein biochemistry, discoverer of the essential amino acid distinction, and 20th president of the German Academy Leopoldina from 1932 to 1950.
Emil C. Gotschlich
Emil C. Gotschlich (1935–2023) was an American physician and molecular chemist at Rockefeller University who developed the first effective vaccine against meningococcal meningitis and did foundational research on the gonococcus.
Emil du Bois-Reymond
Emil du Bois-Reymond (1818–1896) was a German physiologist born and died in Berlin, remembered as the founder of electrophysiology, demonstrating the electrical nature of the nerve signal.
Emil Frei
Emil Frei III (1924–2013), known as Emil "Tom" Frei, was an American oncologist called the father of combination chemotherapy, whose work at Dana-Farber helped make childhood leukemia curable.
Emil Holmgren
Emil Holmgren (Emil Algot Holmgren) was a Swedish histologist and professor at the Karolinska Institute, known for studies of nerve cells and the contested trophospongium theory.
Emil J. Freireich
Emil J. Freireich (E J Freireich) was an American hematologist whose work on combination chemotherapy and platelet transfusion raised childhood leukemia five-year survival above 80 percent.
Emil Kraepelin
Emil Kraepelin (1856–1926), German psychiatrist, founder of modern psychiatric nosology; 1899 textbook dichotomy of dementia praecox (schizophrenia) versus manic-depressive insanity (bipolar disorder); also known for eugenic, racist, and anti-Semitic views.
Emil L. Smith
Emil L. Smith (1911–2009) was an American biochemist who pioneered determining amino acid sequences of proteins and was elected to the National Academy of Sciences in 1962.
Emil R. Unanue
Emil R. Unanue (Emil Raphael Unanue, 1934–2022) was a Cuban-born American immunologist who defined antigen presentation, led Washington University's pathology department, and won the 1995 Lasker Award.
Emil Racoviță
Emil Racoviță (1868–1947) was a Romanian biologist and polar explorer who served as naturalist on the Belgian Antarctic Expedition aboard the Belgica and founded biospeleology.
Emil von Behring
Emil Adolf von Behring (1854–1917) was a German bacteriologist who won the first Nobel Prize in Physiology or Medicine in 1901 for diphtheria serum therapy.
Emil von Dungern
Emil von Dungern (1867–1961) was a German physician and serologist who, working with Ludwik Hirszfeld at Heidelberg, first demonstrated in 1910 that ABO blood groups are inherited.
Émile Brumpt
Émile Brumpt (1877–1951) was a French physician and zoologist, professor of parasitology at Paris from 1919 to 1948, regarded as the originator of medical parasitology in France.
Émile Duclaux
Émile Duclaux (1840–1904) was a French chemist and microbiologist, Louis Pasteur's first and closest collaborator, who directed the Institut Pasteur from 1895 to 1904 and defended Alfred Dreyfus.
Emile E. Voest
Emile E. Voest is a Dutch medical oncologist, professor at UMC Utrecht and senior group leader at the Netherlands Cancer Institute, known for pan-cancer whole-genome sequencing of metastatic tumors.
Émile Roux
Émile Roux, born Pierre Paul Émile Roux (1853–1933), was a French physician and bacteriologist who discovered diphtheria toxin with Alexandre Yersin in 1888 and developed its antitoxin.
Emile S. Gardiner
Emile S. Gardiner is an American research forester with the U.S. Forest Service Southern Research Station in Stoneville, Mississippi, known for work on oak regeneration and restoring bottomland hardwood forests on former farmland.
Emili Montserrat
Emili Montserrat is a Spanish hematologist at the University of Barcelona known for research on chronic lymphocytic leukemia and for introducing ZAP-70 as a prognostic marker.
Emiliana Borrelli
Emiliana Borrelli is an Italian-born neuroscientist, trained in Naples, Strasbourg, and at the Salk Institute, known for cloning the dopamine D2 receptor and generating the first mice lacking it.
Emilio Bizzi
Emilio Bizzi is an Italian-born neuroscientist, born in Rome, who joined MIT in 1969 and is known for the equilibrium-point hypothesis and spinal muscle synergies.
Emilio Bouza
Emilio Bouza Santiago, born 1947 in Vilalba, Spain, is a physician-scientist credited with introducing modern infectology there, leading clinical microbiology at Madrid's Hospital Gregorio Marañón from 1984 to 2017.
Emilio Hirsch
Emilio Hirsch is a molecular biologist and professor of experimental biology at the University of Turin, known for showing that PI3K signaling enzymes are distinct drug targets.